Clinical Trial Update: National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial [Phase 2]

View source ↗

Summary

A Phase 2 neuroprotection trial for Parkinson's disease conducted by NINDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Rochester | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED